Cargando…

GPR91 Receptor Mediates Protection against Doxorubicin-Induced Cardiotoxicity without Altering Its Anticancer Efficacy. An In Vitro Study on H9C2 Cardiomyoblasts and Breast Cancer-Derived MCF-7 Cells

Doxorubicin (DOX) is an anticancer drug widely used in oncology, especially for breast cancer. The main limitation of DOX treatment is its cardiotoxicity due to the cumulative dose. Clinically, DOX-induced cardiomyopathy develops as a progressive heart failure caused by a progressive cardiomyocyte’s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dallons, Matthieu, Alpan, Esma, Schepkens, Corentin, Tagliatti, Vanessa, Colet, Jean-Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599858/ https://www.ncbi.nlm.nih.gov/pubmed/32992522 http://dx.doi.org/10.3390/cells9102177

Ejemplares similares

New Insights About Doxorubicin-Induced Toxicity to Cardiomyoblast-Derived H9C2 Cells and Dexrazoxane Cytoprotective Effect: Contribution of In Vitro (1)H-NMR Metabonomics
por: Dallons, Matthieu, et al.
Publicado: (2020)

A Comparative Study of Rat Urine (1)H-NMR Metabolome Changes Presumably Arising from Isoproterenol-Induced Heart Necrosis Versus Clarithromycin-Induced QT Interval Prolongation
por: Dallons, Matthieu, et al.
Publicado: (2020)

A New Classification Method of Metastatic Cancers Using a (1)H-NMR-Based Approach: A Study Case of Melanoma, Breast, and Prostate Cancer Cell Lines
por: Schepkens, Corentin, et al.
Publicado: (2019)

Lipid Emulsion Inhibits the Late Apoptosis/Cardiotoxicity Induced by Doxorubicin in Rat Cardiomyoblasts
por: Subbarao, Raghavendra Baregundi, et al.
Publicado: (2018)

Metabolic Reprogramming in Metastatic Melanoma with Acquired Resistance to Targeted Therapies: Integrative Metabolomic and Proteomic Analysis
por: Soumoy, Laura, et al.
Publicado: (2020)

Melissa officinalis Protects against Doxorubicin-Induced Cardiotoxicity in Rats and Potentiates Its Anticancer Activity on MCF-7 Cells
por: Hamza, Alaaeldin Ahmed, et al.
Publicado: (2016)

Subcellular localization of anthracyclines in cultured rat cardiomyoblasts as possible predictors of cardiotoxicity
por: Studzian, Kazimierz, et al.
Publicado: (2015)

Capparis spinosa reduces Doxorubicin-induced cardio-toxicity in cardiomyoblast cells
por: Mousavi, Seyed Hadi, et al.
Publicado: (2016)

Icariin Protects H9c2 Rat Cardiomyoblasts from Doxorubicin-Induced Cardiotoxicity: Role of Caveolin-1 Upregulation and Enhanced Autophagic Response
por: Scicchitano, Miriam, et al.
Publicado: (2021)

Flavonoids from Hippophae rhamnoides Linn. Revert Doxorubicin-Induced Cardiotoxicity through Inhibition of Mitochondrial Dysfunction in H9c2 Cardiomyoblasts In Vitro
por: Zhou, Wenna, et al.
Publicado: (2023)

Receptors of intermediates of carbohydrate metabolism, GPR91 and GPR99, mediate axon growth
por: Cherif, Hosni, et al.
Publicado: (2018)

Anticancer prodrugs of butyric acid and formaldehyde protect against doxorubicin-induced cardiotoxicity
por: Rephaeli, A, et al.
Publicado: (2007)

GPR91: expanding the frontiers of Krebs cycle intermediates
por: de Castro Fonseca, Matheus, et al.
Publicado: (2016)

Hydropersulfides (RSSH) attenuate doxorubicin-induced cardiotoxicity while boosting its anticancer action
por: Pharoah, Blaze M., et al.
Publicado: (2023)

Targeting Metabolic Reprogramming to Improve Breast Cancer Treatment: An In Vitro Evaluation of Selected Metabolic Inhibitors Using a Metabolomic Approach
por: Draguet, Anaïs, et al.
Publicado: (2021)

INKing the Cardiotoxicity Out of Doxorubicin
por: Guo, Zhen, et al.
Publicado: (2023)

Dendrimer-doxorubicin conjugates exhibit improved anticancer activity and reduce doxorubicin-induced cardiotoxicity in a murine hepatocellular carcinoma model
por: Kuruvilla, Sibu P., et al.
Publicado: (2017)

Schisandrin B Prevents Doxorubicin-Induced Chronic Cardiotoxicity and Enhances Its Anticancer Activity In Vivo
por: Xu, Yang, et al.
Publicado: (2011)

Sulforaphane potentiates anticancer effects of doxorubicin and attenuates its cardiotoxicity in a breast cancer model
por: Bose, Chhanda, et al.
Publicado: (2018)

R-(-)-carvone Attenuated Doxorubicin Induced Cardiotoxicity In Vivo and Potentiated Its Anticancer Toxicity In Vitro
por: Abbas, Manal Mohammad, et al.
Publicado: (2020)

Ginsenoside Rg3 micelles mitigate doxorubicin-induced cardiotoxicity and enhance its anticancer efficacy
por: Li, Lan, et al.
Publicado: (2017)

Cardiotoxicity of Anticancer Therapeutics
por: Dong, Jerry, et al.
Publicado: (2018)

Succinate causes pathological cardiomyocyte hypertrophy through GPR91 activation
por: Aguiar, Carla J, et al.
Publicado: (2014)

Protective Effect of Hibiscus Sabdariffa on Doxorubicin-induced Cytotoxicity in H9c2 Cardiomyoblast Cells
por: Hosseini, Azar, et al.
Publicado: (2017)

Correction: Schisandrin B Prevents Doxorubicin-Induced Chronic Cardiotoxicity and Enhances Its Anticancer Activity In Vivo
por: Xu, Yang, et al.
Publicado: (2012)

Role of acetylation in doxorubicin-induced cardiotoxicity
por: Li, Daisong, et al.
Publicado: (2021)

Dipyridamole ameliorates doxorubicin-induced cardiotoxicity
por: Alyasiry, Esraa, et al.
Publicado: (2022)

The fate of P2Y-related orphan receptors: GPR80/99 and GPR91 are receptors of dicarboxylic acids
por: Gonzalez, Nathalie Suarez, et al.
Publicado: (2004)

Predicting Valproate-Induced Liver Injury Using Metabolomic Analysis of Ex Ovo Chick Embryo Allantoic Fluid
por: Tagliatti, Vanessa, et al.
Publicado: (2023)

The Succinate Receptor GPR91 Is Involved in Pressure Overload-Induced Ventricular Hypertrophy
por: Yang, Lei, et al.
Publicado: (2016)

Succinate induces aberrant mitochondrial fission in cardiomyocytes through GPR91 signaling
por: Lu, Yi-Tong, et al.
Publicado: (2018)

Inhibition of GPR91 Reduces Inflammatory Mediators Involved in Active Labor in Myometrium
por: Lim, Ratana, et al.
Publicado: (2020)

Cardiotoxicity of Contemporary Anticancer Immunotherapy
por: Dal’bo, Natalie, et al.
Publicado: (2020)

Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells
por: Wang, Xu, et al.
Publicado: (2019)

Protein-encapsulated doxorubicin reduces cardiotoxicity in hiPSC-cardiomyocytes and cardiac spheroids while maintaining anticancer efficacy
por: Arzt, Madelyn, et al.
Publicado: (2023)

Morphine Enhances Doxorubicin-Induced Cardiotoxicity in the Rat
por: Hole, Lisa Drange, et al.
Publicado: (2014)

The true colors of autophagy in doxorubicin-induced cardiotoxicity
por: Xiao, Bin, et al.
Publicado: (2019)

UVRAG Deficiency Exacerbates Doxorubicin-Induced Cardiotoxicity
por: An, Lin, et al.
Publicado: (2017)

Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity
por: Koleini, Navid, et al.
Publicado: (2017)

Telomerase therapy attenuates cardiotoxic effects of doxorubicin
por: Chatterjee, Shambhabi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5t3adeitmdla504m2g42tq7hkm